We endeavored to support this claim by using in our infection model system, the two IAV H1N1 strains (one lab and one clinical), three human cell lines (one of them bronchial and one alveolar), gene depletion and overexpression, and purified IFNα treatment. This evidence concerns the gene IFNA1 and infection.